2025-2031 Global Rydapt Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > 2025-2031 Global Rydapt Industry Research & Trends Analysis Report

2025-2031 Global Rydapt Industry Research & Trends Analysis Report

Publication Date: 2025-08-25
Report Id: 2362832
Industry: Pharma & Healthcare
Report Page: 112
Chart: 110

PDF Download

Publication Date: 2025-08-25
Report Id: 2362832
Industry: Pharma & Healthcare
Report Page: 112
Chart: 110

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Rydapt Definition
1.2 Global Rydapt Market Size and Forecast
1.2.1 By Revenue, Global Rydapt Market Size, 2020-2031
1.2.2 By Sales Volume, Global Rydapt Market Size, 2020-2031
1.2.3 Global Rydapt Price Trend, 2020-2031
1.3 China Rydapt Market Size and Forecast
1.3.1 By Revenue, China Rydapt Market Size, 2020-2031
1.3.2 By Sales Volume, China Rydapt Market Size, 2020-2031
1.3.3 China Rydapt Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Rydapt Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Rydapt Share in Global Market, 2020-2031
1.4.3 Rydapt Market Size: China VS Global, 2020-2031
1.5 Rydapt Market Dynamics
1.5.1 Rydapt Market Drivers
1.5.2 Rydapt Market Restraints
1.5.3 Rydapt Industry Trends
1.5.4 Rydapt Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Rydapt Revenue by Company, 2020-2025
2.2 Global Rydapt Sales Volume by Company, 2020-2025
2.3 Global Rydapt Price by Company, 2020-2025
2.4 Global Rydapt Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Rydapt Concentration Ratio
2.6 Global Rydapt Mergers & Acquisitions, Expansion Plans
2.7 Global Rydapt Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Rydapt Revenue by Company, 2020-2025
3.2 China Rydapt Sales Volume by Company, 2020-2025
3.3 China Rydapt Rydapt Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Rydapt Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Rydapt Domestic VS Export
3.6 China Market, Rydapt Import & Export
3.6.1 China Market, Rydapt Import & Export, 2020-2031
3.6.2 China Rydapt Import & Export Trends
3.6.3 Main Sources of China Rydapt Import
3.6.4 Export Destination of China Rydapt

4 Rydapt Production by Region
4.1 Global Rydapt Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Rydapt Manufacturers
4.3 Global Major Manufacturers, Rydapt Capacity Expansion and Future Plans
4.4 Global Rydapt Capacity by Region
4.5 Global Rydapt Production by Region
4.5.1 Global Rydapt Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Rydapt Production by Region, 2020-2025
4.5.3 Global Rydapt Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Rydapt Industry Chain
5.2 Rydapt Upstream Analysis
5.2.1 Rydapt Core Raw Materials
5.2.2 Main Manufacturers of Rydapt Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Rydapt Production Mode
5.6 Rydapt Procurement Model
5.7 Rydapt Industry Sales Model and Sales Channels
5.7.1 Rydapt Sales Model
5.7.2 Rydapt Typical Distributors

6 Sights by Product Type
6.1 Rydapt Classification
6.1.1 AML
6.1.2 ASM, SM-AHN, or MCL
6.2 by Type, Global Rydapt Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Rydapt Revenue, 2020-2031
6.4 by Type, Global Rydapt Sales Volume, 2020-2031
6.5 by Type, Global Rydapt Price, 2020-2031

7 Sights by Application
7.1 Rydapt Segment by Application
7.1.1 Hospital
7.1.2 Pharmacy
7.2 by Application, Global Rydapt Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Rydapt Revenue, 2020-2031
7.4 by Application, Global Rydapt Sales Volume, 2020-2031
7.5 by Application, Global Rydapt Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Rydapt Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Rydapt Revenue, 2020-2031
8.3 By Region, Global Rydapt Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Rydapt Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Rydapt Market Size Market Share
8.5 Europe
8.5.1 Europe Rydapt Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Rydapt Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Rydapt Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Rydapt Market Size Market Share
8.7 South America
8.7.1 South AmericaRydapt Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Rydapt Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Rydapt Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global Rydapt Revenue, 2020-2031
9.3 By Country, Global Rydapt Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Rydapt Market Size, 2020-2031
9.4.2 By Company, United States Rydapt Sales Volume Market Share, 2024
9.4.3 by Type, United States Rydapt Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Rydapt Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Rydapt Market Size, 2020-2031
9.5.2 By Company, Europe Rydapt Sales Volume Market Share, 2024
9.5.3 by Type, Europe Rydapt Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Rydapt Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Rydapt Market Size, 2020-2031
9.6.2 By Company, China Rydapt Sales Volume Market Share, 2024
9.6.3 by Type, China Rydapt Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Rydapt Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Rydapt Market Size, 2020-2031
9.7.2 By Company, Japan Rydapt Market Share, 2024
9.7.3 by Type, Japan Rydapt Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Rydapt Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Rydapt Market Size, 2020-2031
9.8.2 By Company, South Korea Rydapt Market Share, 2024
9.8.3 by Type, South Korea Rydapt Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Rydapt Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Rydapt Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Rydapt Market Share, 2024
9.9.3 by Type, Southeast Asia Rydapt Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Rydapt Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Rydapt Market Size, 2020-2031
9.10.2 By Company, India Rydapt Market Share, 2024
9.10.3 by Type, India Rydapt Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Rydapt Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Rydapt Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Rydapt Market Share, 2024
9.11.3 by Type, Middle East & Africa Rydapt Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Rydapt Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Novartis
10.1.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.1.2 Novartis Rydapt Models, Specifications, and Application
10.1.3 Novartis Rydapt Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Novartis Company Profile and Main Business
10.1.5 Novartis Recent Developments
10.2 Glenmark Pharmaceuticals
10.2.1 Glenmark Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.2.2 Glenmark Pharmaceuticals Rydapt Models, Specifications, and Application
10.2.3 Glenmark Pharmaceuticals Rydapt Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Glenmark Pharmaceuticals Company Profile and Main Business
10.2.5 Glenmark Pharmaceuticals Recent Developments
10.3 Zydus Cadila
10.3.1 Zydus Cadila Company Information, Head Office, Market Area, and Industry Position
10.3.2 Zydus Cadila Rydapt Models, Specifications, and Application
10.3.3 Zydus Cadila Rydapt Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Zydus Cadila Company Profile and Main Business
10.3.5 Zydus Cadila Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Rydapt should grow from US$ 356 million in 2024 to US$ 588 million by 2031, with a CAGR of 6.9% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Rydapt

According to YH Research, the global market for Rydapt should grow from US$ 356 million in 2024 to US$ 588 million by 2031, with a CAGR of 6.9% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Rydapt is an oral small-molecule tyrosine kinase inhibitor primarily indicated for certain types of acute myeloid leukemia (AML) and systemic mastocytosis (SM). As a targeted therapy, Rydapt selectively inhibits signaling pathways associated with FLT3 gene mutations, thereby blocking the proliferation and survival of cancer cells. The drug has been approved by the U.S. FDA and the European EMA, becoming a standard treatment option for FLT3-positive AML patients. Often administered in combination with standard chemotherapy, Rydapt improves remission rates and overall survival, showing significant efficacy in both newly diagnosed and relapsed/refractory AML patients. The development and commercialization of Midostaurin represent a major advancement in precision medicine within hematologic oncology, greatly expanding targeted therapeutic options for AML.In 2024, global Rydapt production reached approximately 2.84 million unit, with an average global market price of around US$ 118/unit
With the widespread adoption of precision medicine and genetic testing technologies, detection rates of FLT3 gene mutations have significantly increased, expanding Rydapt’s applicable patient population in AML. Corporate reports show that the global aging population and steady rise in AML incidence, particularly in developed countries, drive sustained demand for Rydapt. Multiple clinical studies confirm that Rydapt combined with standard chemotherapy substantially improves patient outcomes, earning guideline endorsements and enhancing market acceptance. Increased pharmaceutical investment in innovative targeted therapies promotes development of new indications and combination regimens, extending product lifecycle. Gradual inclusion in insurance coverage and streamlined market access reduce patient financial burden, expanding market penetration.

Despite promising prospects, Rydapt faces several challenges. High R&D and manufacturing costs lead to expensive treatment regimens, limiting accessibility in some regions. AML heterogeneity causes resistance to FLT3 inhibitors in certain patients, affecting sustained efficacy. Emerging competitors are launching more selective, potent next-generation FLT3 inhibitors, intensifying market competition. Additionally, underdeveloped healthcare reimbursement in emerging markets slows rapid adoption. Safety risk management and adverse event monitoring remain critical to ensure patient safety and regulatory compliance.

As molecular diagnostics mature, clinical demand for precise subtyping and personalized treatment is growing, driving Rydapt’s use into early diagnosis and maintenance therapy. Pharmaceutical distribution channels and major hospitals steadily increase procurement of targeted therapies, especially in North America, Europe, and leading Chinese cities. Rising patient and physician acceptance of innovative therapies promotes market penetration. The rise of digital and remote healthcare platforms facilitates easier access to genetic testing and targeted medication, enhancing coverage. Strengthened collaborations between multinational pharma and local healthcare institutions support global commercial expansion of Rydapt.

This report aims to provide a comprehensive study of the global market for Rydapt.
Report Highlights:
(1) Global Rydapt market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Rydapt market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Rydapt market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Rydapt segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Rydapt segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Rydapt, capacity, production and trends.

(7) Rydapt industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
AML
ASM, SM-AHN, or MCL

Market segment by Application, can be divided into
Hospital
Pharmacy

Market segment by players, this report covers
Novartis
Glenmark Pharmaceuticals
Zydus Cadila